Figure legends
Figure 1. Correlation analysis of the ILC2 prevalence in
sinonasal tissues and in preoperative (pre-op) blood. Correlations
between the ILC2 prevalence in sinonasal tissues and that in pre-op
blood (A), the ILC2 prevalence in sinonasal tissues and the pre-op
Lund-Mackay CT (LMK-CT) score (B), the ILC2 prevalence in pre-op blood
and the pre-op LMK-CT score (C), the ILC2 prevalence in sinonasal
tissues and the postoperative (post-op) LMK-CT score (D), and the ILC2
prevalence in pre-op blood and the post-op LMK-CT score (E). eCRS,
eosinophilic chronic rhinosinusitis.
Figure 2. Correlation analysis of the ILC2 prevalence in
sinonasal tissues and in pre-op blood with the post-op outcomes in the
eCRS and non-eCRS patients. Correlations between the ILC2 prevalence in
sinonasal tissues and the post-op LMK-CT score improvement rate (A), and
the ILC2 prevalence in pre-op blood and the post-op LMK-CT score
improvement rate (B).
Figure 3. Changes in the ILC2 prevalence in blood (A) and in
the LMK-CT score (B) before and after ESS.
Figure 4. Changes in the ILC2 prevalence in blood before and
after ESS in the good outcome group (A) and the poor outcome group (B).